 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDoes EXTENDED PHENYTOIN SODIUM increase or decrease the risk [0m
[34mof bleeding?[0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.AGENT [0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mrecipient_message[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"recipient_message"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"intended_recipient"[0m[32m: [0m[32m"FDAHandler"[0m[32m,[0m
[32m    [0m[32m"content"[0m[32m: [0m[32m"Does EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.AGENT [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [32mDoes EXTENDED PHENYTOIN SODIUM increase or decrease the risk [0m
[32mof bleeding?[0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDoes EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?[0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mrelevant_extracts[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"relevant_extracts"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"query"[0m[32m: [0m[32m"Does EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?"[0m[32m,[0m
[32m    [0m[32m"filter_drugs"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"EXTENDED PHENYTOIN SODIUM"[0m
[32m    [0m[1;32m][0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mrelevant_extracts[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Below are some relevant extracts for your query:[0m
[31m        -----[0m
[31m        [0m
[31mCONTENT: EXTENDED PHENYTOIN SODIUM: pregnancy: [0m[1;31m8.1[0m[31m Pregnancy Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs[0m
[1;31m([0m[31mAEDs[0m[1;31m)[0m[31m, such as phenytoin sodium, during pregnancy. Physicians are advised to recommend that pregnant patients taking phenytoin sodium enroll in the North American Antiepileptic Drug [0m[1;31m([0m[31mNAAED[0m[1;31m)[0m[31m Pregnancy[0m
[31mRegistry. This can be done by calling the toll free number [0m[1;31m1[0m[31m-[0m[1;31m888[0m[31m-[0m[1;31m233[0m[31m-[0m[1;31m2334[0m[31m, and must be done by patients themselves. Information on the registry can also be found at the website [0m
[4;31mhttp://www.aedpregnancyregistry.org/[0m[31m Risk Summary In humans, prenatal exposure to phenytoin may increase the risks for congenital malformations and other adverse developmental outcomes. Prenatal [0m
[31mphenytoin exposure is associated with an increased incidence of major malformations, including orofacial clefts and cardiac defects. EXTENDED PHENYTOIN SODIUM: pregnancy: In addition, the fetal [0m
[31mhydantoin syndrome, a pattern of abnormalities including dysmorphic skull and facial features, nail and digit hypoplasia, growth abnormalities [0m[1;31m([0m[31mincluding microcephaly[0m[1;31m)[0m[31m, and cognitive deficits has been[0m
[31mreported among children born to epileptic women who took phenytoin alone or in combination with other antiepileptic drugs during pregnancy [0m[31m . There have been several reported cases of malignancies, [0m
[31mincluding neuroblastoma, in children whose mothers received phenytoin during pregnancy. Administration of phenytoin to pregnant animals resulted in an increased incidence of fetal malformations and [0m
[31mother manifestations of developmental toxicity [0m[1;31m([0m[31mincluding embryofetal death, growth impairment, and behavioral abnormalities[0m[1;31m)[0m[31m in multiple species at clinically relevant doses [0m[31m. In the U.S. general [0m
[31mpopulation, the estimated background risk of major birth defects and of miscarriage in clinically recognized pregnancies is [0m[1;31m2[0m[31m% to [0m[1;31m4[0m[31m% and [0m[1;31m15[0m[31m% to [0m[1;31m20[0m[31m%, respectively. EXTENDED PHENYTOIN SODIUM: pregnancy:[0m
[31mThe background risk of major birth defects and miscarriage for the indicated population is unknown. Clinical Considerations Disease-associated maternal risk An increase in seizure frequency may occur [0m
[31mduring pregnancy because of altered phenytoin pharmacokinetics. Periodic measurement of serum phenytoin concentrations may be valuable in the management of pregnant women as a guide to appropriate [0m
[31madjustment of dosage [0m[31m . However, postpartum restoration of the original dosage will probably be indicated [0m[31m. Fetal/Neonatal Adverse Reactions A potentially life-threatening bleeding disorder related to[0m
[31mdecreased levels of vitamin K-dependent clotting factors may occur in newborns exposed to phenytoin in utero . This drug-induced condition can be prevented with vitamin K administration to the mother [0m
[31mbefore delivery and to the neonate after birth. EXTENDED PHENYTOIN SODIUM: pregnancy: Data Human Data Meta-analyses using data from published observational studies and registries have estimated an [0m
[31mapproximately [0m[1;31m2.4[0m[31m-fold increased risk for any major malformation in children with prenatal phenytoin exposure compared to controls. An increased risk of heart defects, facial clefts, and digital [0m
[31mhypoplasia has been reported. The fetal hydantoin syndrome is a pattern of congenital anomalies including craniofacial anomalies, nail and digital hypoplasia, prenatal-onset growth deficiency, and [0m
[31mneurodevelopmental deficiencies. Animal Data Administration of phenytoin to pregnant rats, rabbits, and mice during organogenesis resulted in embryofetal death, fetal malformations, and decreased [0m
[31mfetal growth. Malformations [0m[1;31m([0m[31mincluding craniofacial, cardiovascular, neural, limb, and digit abnormalities[0m[1;31m)[0m[31m were observed in rats, rabbits, and mice at doses as low as [0m[1;31m100[0m[31m, [0m[1;31m75[0m[31m, and [0m[1;31m12.5[0m[31m mg/kg, [0m
[31mrespectively.         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: spl_medguide_table: content>[0m[1;31m<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>Extended phenytoin sodium capsules are a prescription medicine used to treat certain types of seizures called [0m
[31mtonic-clonic [0m[1;31m([0m[31mgrand mal[0m[1;31m)[0m[31m and psychomotor [0m[1;31m([0m[31mtemporal lobe[0m[1;31m)[0m[31m seizures.<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m" Botrule Toprule Lrule Rrule"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Do not [0m
[31mtake<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules if you:<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Are allergic to phenytoin or any of the [0m
[31mingredients in extended phenytoin sodium capsules. See the end of this leaflet for a complete list of ingredients in extended phenytoin sodium capsules.<[0m[31m/[0m[31mitem[0m[31m><item>Have had an allergic reaction to [0m
[31mCEREBYX [0m[1;31m([0m[31mfosphenytoin[0m[1;31m)[0m[31m, PEGANONE [0m[1;31m([0m[31methotoin[0m[1;31m)[0m[31m, or MESANTOIN [0m[1;31m([0m[31mmephenytoin[0m[1;31m)[0m[31m. EXTENDED PHENYTOIN SODIUM: spl_medguide_table: item><item>Have had liver problems from taking phenytoin.<[0m[31m/[0m[31mitem[0m[31m><item>Take [0m
[31mdelavirdine.<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Before taking<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules, tell your healthcare provider about all of your [0m
[31mmedical conditions, including if you:<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Have or have had depression, mood problems, or suicidal thoughts or [0m
[31mbehavior<[0m[31m/[0m[31mitem[0m[31m><item>Have had an allergic reaction to a medicine similar to extended phenytoin sodium capsules called carboxamides, barbiturates, succinimides, and oxazolidinediones<[0m[31m/[0m[31mitem[0m[31m><item>Have [0m
[31mor had liver or kidney problems<[0m[31m/[0m[31mitem[0m[31m><item>Have or had an enzyme problem called porphyria<[0m[31m/[0m[31mitem[0m[31m><item>Have or had high blood sugar [0m[1;31m([0m[31mhyperglycemia[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item>Drink alcohol<[0m[31m/[0m[31mitem[0m[31m><item EXTENDED [0m
[31mPHENYTOIN SODIUM: spl_medguide_table: >Are pregnant or plan to become pregnant. Extended phenytoin sodium capsules may harm your unborn baby.<[0m[31m/[0m[31mitem[0m[31m><item>If you take extended phenytoin sodium capsules[0m
[31mduring pregnancy, your baby is at risk for serious birth defects.<[0m[31m/[0m[31mitem[0m[31m><item>If you become pregnant while taking extended phenytoin sodium capsules, the level of phenytoin in your blood may decrease,[0m
[31mcausing your seizures to become worse. Your healthcare provider may change your dose of extended phenytoin sodium capsules.<[0m[31m/[0m[31mitem[0m[31m><item>If you take extended phenytoin sodium capsules during pregnancy,[0m
[31myour baby is also at risk for bleeding problems right after birth. Your healthcare provider may give you and your baby medicine to prevent this.<[0m[31m/[0m[31mitem[0m[31m><item>All women of child-bearing age should talk [0m
[31mto their healthcare provider about using other possible treatments instead of extended phenytoin sodium capsules. EXTENDED PHENYTOIN SODIUM: spl_medguide_table: item><item>If you are of childbearing [0m
[31mage and are not planning on getting pregnant, you should use effective birth control [0m[1;31m([0m[31mcontraception[0m[1;31m)[0m[31m while taking extended phenytoin sodium capsules.<[0m[31m/[0m[31mitem[0m[31m><item><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Pregnancy [0m
[31mRegistry:<[0m[31m/[0m[31mcontent[0m[31m>If you become pregnant while taking extended phenytoin sodium capsules, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy [0m
[31mRegistry. You can enroll in this registry by calling [0m[1;31m1[0m[31m-[0m[1;31m888[0m[31m-[0m[1;31m233[0m[31m-[0m[1;31m2334[0m[31m. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. <[0m[31m/[0m[31mitem[0m[31m><item>Are [0m
[31mbreastfeeding or plan to breastfeed. Phenytoin can pass into breast milk. You and your healthcare provider should decide if you will take extended phenytoin sodium capsules while you are [0m
[31mbreastfeeding. EXTENDED PHENYTOIN SODIUM: spl_medguide_table: item><[0m[31m/[0m[31mlist[0m[31m><paragraph>Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter [0m
[31mmedicines, vitamins, and herbal supplements. These medicines can change the levels of phenytoin in your blood.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>Taking extended phenytoin sodium capsules with certain other [0m
[31mmedicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>Know the medicines you take. Keep[0m
[31ma list of them and show it to your healthcare provider and pharmacist when you get a new medicine.<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m" Botrule Toprule Lrule Rrule"[0m[31m><paragraph><content [0m
[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>How should I take<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules? EXTENDED PHENYTOIN SODIUM: spl_medguide_table: content><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m
[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Take extended phenytoin sodium capsules exactly as your healthcare provider tells you.<[0m[31m/[0m[31mitem[0m[31m><item>Your healthcare provider will tell you how much extended phenytoin sodium [0m
[31mcapsules to take and when to take it.<[0m[31m/[0m[31mitem[0m[31m><item>Your healthcare provider may change your dose if needed. Do not change your dose of extended phenytoin sodium capsules without talking to your [0m
[31mhealthcare provider.<[0m[31m/[0m[31mitem[0m[31m><item>Do not stop taking extended phenytoin sodium capsules without first talking to your healthcare provider. Stopping extended phenytoin sodium capsules suddenly can cause[0m
[31mserious problems.<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m" Botrule Toprule Lrule Rrule"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>What should I avoid while taking<[0m[31m/[0m[31mcontent[0m[31m><content [0m
[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules? EXTENDED PHENYTOIN SODIUM: spl_medguide_table: content><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Do not drink alcohol while you[0m
[31mtake extended phenytoin sodium capsules without first talking to your healthcare provider. Drinking alcohol while taking extended phenytoin sodium capsules may change your blood levels of phenytoin [0m
[31mwhich can cause serious problems.<[0m[31m/[0m[31mitem[0m[31m><item>Do not drive, operate heavy machinery, or do other dangerous activities until you know how extended phenytoin sodium capsules affects you. Extended [0m
[31mphenytoin sodium capsules can slow your thinking and motor skills.<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m" Botrule Toprule Lrule Rrule"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>What are the possible [0m
[31mside effects of<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules? EXTENDED PHENYTOIN SODIUM: spl_medguide_table: content><[0m[31m/[0m[31mparagraph[0m[31m><paragraph>See &#x201C; <content [0m
[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>What is the most important information I should know about<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin sodium capsules?&#x201D;<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><paragraph><content [0m
[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Extended phenytoin sodium capsules may cause other serious side effects including:<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Liver [0m
[31mproblems.<[0m[31m/[0m[31mitem[0m[31m><item>Low blood count which could increase your chance of getting infections, bruising, bleeding and increased fatigue.<[0m[31m/[0m[31mitem[0m[31m><item>Softening of your bones [0m[1;31m([0m[31mosteopenia, osteoporosis, [0m
[31mand osteomalacia[0m[1;31m)[0m[31m can cause your bones to break [0m[1;31m([0m[31mfractures[0m[1;31m)[0m[31m.<[0m[31m/[0m[31mitem[0m[31m><item>High blood sugar [0m[1;31m([0m[31mhyperglycemia[0m[1;31m)[0m[31m. EXTENDED PHENYTOIN SODIUM: spl_medguide_table: item><item>High levels of phenytoin in your [0m
[31mblood that could cause confusion also known as delirium, psychosis or a more serious condition that affects how your brain works [0m[1;31m([0m[31mencephalopathy[0m[1;31m)[0m[31m.<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><paragraph>Call your healthcare provider[0m
[31mright away, if you have any of the symptoms listed above.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>The most common side effects of extended phenytoin sodium capsules include:<[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m
[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Irregular movement of the eye [0m[1;31m([0m[31mnystagmus[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item>Slurred speech<[0m[31m/[0m[31mitem[0m[31m><item>Drowsiness [0m[1;31m([0m[31msomnolence[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item>Problems with movement and balance [0m
[1;31m([0m[31mataxia[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item>Decrease in coordination<[0m[31m/[0m[31mitem[0m[31m><item>Confusion<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><paragraph>Extended phenytoin sodium capsules can cause overgrowth of your gums. EXTENDED PHENYTOIN SODIUM: [0m
[31mspl_medguide_table: Brushing and flossing your teeth and seeing a dentist regularly while taking extended phenytoin sodium capsules can help prevent this from happening.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>These [0m
[31mare not all of the possible side effects of extended phenytoin sodium capsules.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>Call your doctor for medical advice about side effects. You may report side effects to FDA at [0m
[1;31m1[0m[31m-[0m[1;31m800[0m[31m-FDA-[0m[1;31m1088[0m[31m.<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m" Botrule Toprule Lrule Rrule"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>How should I store<[0m[31m/[0m[31mcontent[0m[31m><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>extended phenytoin [0m
[31msodium capsules?<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Disc"[0m[31m><item>Store extended phenytoin sodium capsules at room temperature between [0m[1;31m68[0m[31m&#xB0;F to [0m[1;31m77[0m[31m&#xB0;F [0m[1;31m([0m[1;31m20[0m[31m&#xB0;C to [0m
[1;31m25[0m[31m&#xB0;C[0m[1;31m)[0m[31m.         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: spl_medguide: Extended phenytoin sodium capsules can cause problems with your heart, including a slow heartbeat. Let your healthcare provider know right away if you[0m
[31mhave any of these symptoms: dizziness tiredness feeling like your heart is beating slowly or skipping beats chest pain What are extended phenytoin sodium capsules? Extended phenytoin sodium capsules [0m
[31mare a prescription medicine used to treat certain types of seizures called tonic-clonic [0m[1;31m([0m[31mgrand mal[0m[1;31m)[0m[31m and psychomotor [0m[1;31m([0m[31mtemporal lobe[0m[1;31m)[0m[31m seizures. Do not take extended phenytoin sodium capsules if you: Are[0m
[31mallergic to phenytoin or any of the ingredients in extended phenytoin sodium capsules. See the end of this leaflet for a complete list of ingredients in extended phenytoin sodium capsules. Have had an[0m
[31mallergic reaction to CEREBYX [0m[1;31m([0m[31mfosphenytoin[0m[1;31m)[0m[31m, PEGANONE [0m[1;31m([0m[31methotoin[0m[1;31m)[0m[31m, or MESANTOIN [0m[1;31m([0m[31mmephenytoin[0m[1;31m)[0m[31m. EXTENDED PHENYTOIN SODIUM: spl_medguide: Have had liver problems from taking phenytoin. Take delavirdine. [0m
[31mBefore taking extended phenytoin sodium capsules, tell your healthcare provider about all of your medical conditions, including if you: Have or have had depression, mood problems, or suicidal thoughts[0m
[31mor behavior Have had an allergic reaction to a medicine similar to extended phenytoin sodium capsules called carboxamides, barbiturates, succinimides, and oxazolidinediones Have or had liver or kidney[0m
[31mproblems Have or had an enzyme problem called porphyria Have or had high blood sugar [0m[1;31m([0m[31mhyperglycemia[0m[1;31m)[0m[31m Drink alcohol Are pregnant or plan to become pregnant. Extended phenytoin sodium capsules may harm [0m
[31myour unborn baby. If you take extended phenytoin sodium capsules during pregnancy, your baby is at risk for serious birth defects. EXTENDED PHENYTOIN SODIUM: spl_medguide: If you become pregnant while[0m
[31mtaking extended phenytoin sodium capsules, the level of phenytoin in your blood may decrease, causing your seizures to become worse. Your healthcare provider may change your dose of extended phenytoin[0m
[31msodium capsules. If you take extended phenytoin sodium capsules during pregnancy, your baby is also at risk for bleeding problems right after birth. Your healthcare provider may give you and your baby[0m
[31mmedicine to prevent this. All women of child-bearing age should talk to their healthcare provider about using other possible treatments instead of extended phenytoin sodium capsules. If you are of [0m
[31mchildbearing age and are not planning on getting pregnant, you should use effective birth control [0m[1;31m([0m[31mcontraception[0m[1;31m)[0m[31m while taking extended phenytoin sodium capsules. Pregnancy Registry: If you become [0m
[31mpregnant while taking extended phenytoin sodium capsules, talk to your healthcare provider about registering with the North American Antiepileptic Drug Pregnancy Registry. EXTENDED PHENYTOIN SODIUM: [0m
[31mspl_medguide: You can enroll in this registry by calling [0m[1;31m1[0m[31m-[0m[1;31m888[0m[31m-[0m[1;31m233[0m[31m-[0m[1;31m2334[0m[31m. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. Are [0m
[31mbreastfeeding or plan to breastfeed. Phenytoin can pass into breast milk. You and your healthcare provider should decide if you will take extended phenytoin sodium capsules while you are [0m
[31mbreastfeeding. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. These medicines can change the [0m
[31mlevels of phenytoin in your blood. Taking extended phenytoin sodium capsules with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines [0m
[31mwithout talking to your healthcare provider. Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist when you get a new medicine. How should I take [0m
[31mextended phenytoin sodium capsules? EXTENDED PHENYTOIN SODIUM: spl_medguide: Take extended phenytoin sodium capsules exactly as your healthcare provider tells you. Your healthcare provider will tell [0m
[31myou how much extended phenytoin sodium capsules to take and when to take it. Your healthcare provider may change your dose if needed. Do not change your dose of extended phenytoin sodium capsules [0m
[31mwithout talking to your healthcare provider. Do not stop taking extended phenytoin sodium capsules without first talking to your healthcare provider. Stopping extended phenytoin sodium capsules [0m
[31msuddenly can cause serious problems. What should I avoid while taking extended phenytoin sodium capsules? Do not drink alcohol while you take extended phenytoin sodium capsules without first talking [0m
[31mto your healthcare provider. Drinking alcohol while taking extended phenytoin sodium capsules may change your blood levels of phenytoin which can cause serious problems. Do not drive, operate heavy [0m
[31mmachinery, or do other dangerous activities until you know how extended phenytoin sodium capsules affects you. EXTENDED PHENYTOIN SODIUM: spl_medguide: Extended phenytoin sodium capsules can slow your[0m
[31mthinking and motor skills. What are the possible side effects of extended phenytoin sodium capsules? See “ What is the most important information I should know about extended phenytoin sodium [0m
[31mcapsules?” Extended phenytoin sodium capsules may cause other serious side effects including: Liver problems. Low blood count which could increase your chance of getting infections, bruising, bleeding[0m
[31mand increased fatigue. Softening of your bones [0m[1;31m([0m[31mosteopenia, osteoporosis, and osteomalacia[0m[1;31m)[0m[31m can cause your bones to break [0m[1;31m([0m[31mfractures[0m[1;31m)[0m[31m. High blood sugar [0m[1;31m([0m[31mhyperglycemia[0m[1;31m)[0m[31m. High levels of phenytoin in [0m
[31myour blood that could cause confusion also known as delirium, psychosis or a more serious condition that affects how your brain works [0m[1;31m([0m[31mencephalopathy[0m[1;31m)[0m[31m. Call your healthcare provider right away, if you[0m
[31mhave any of the symptoms listed above. EXTENDED PHENYTOIN SODIUM: spl_medguide: The most common side effects of extended phenytoin sodium capsules include: Irregular movement of the eye [0m[1;31m([0m[31mnystagmus[0m[1;31m)[0m[31m [0m
[31mSlurred speech Drowsiness [0m[1;31m([0m[31msomnolence[0m[1;31m)[0m[31m Problems with movement and balance [0m[1;31m([0m[31mataxia[0m[1;31m)[0m[31m Decrease in coordination Confusion Extended phenytoin sodium capsules can cause overgrowth of your gums. Brushing and[0m
[31mflossing your teeth and seeing a dentist regularly while taking extended phenytoin sodium capsules can help prevent this from happening. These are not all of the possible side effects of extended [0m
[31mphenytoin sodium capsules. Call your doctor for medical advice about side effects. You may report side effects to FDA at [0m[1;31m1[0m[31m-[0m[1;31m800[0m[31m-FDA-[0m[1;31m1088[0m[31m. How should I store extended phenytoin sodium capsules? Store [0m
[31mextended phenytoin sodium capsules at room temperature between [0m[1;31m68[0m[31m°F to [0m[1;31m77[0m[31m°F [0m[1;31m([0m[1;31m20[0m[31m°C to [0m[1;31m25[0m[31m°C[0m[1;31m)[0m[31m. Store in tight, light-resistant containers. Protect from moisture. EXTENDED PHENYTOIN SODIUM: spl_medguide: [0m
[31mKeep extended phenytoin sodium capsules and all medicines out of the reach of children. General information about the safe and effective use of extended phenytoin sodium capsules. Medicines are [0m
[31msometimes prescribed for purposes other than those listed in a Medication Guide. Do not use extended phenytoin sodium capsules for a condition for which it was not prescribed. Do not give extended [0m
[31mphenytoin sodium capsules to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about extended [0m
[31mphenytoin sodium capsules that is written for health professionals. What are the ingredients in extended phenytoin sodium capsules? Extended phenytoin sodium capsules [0m[1;31m100[0m[31m mg: white opaque/light [0m
[31mlavender opaque, hard gelatin capsules imprinted with [0m[31m"IP 212"[0m[31m on both cap and body.         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: openfda: spl_id         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: openfda: product_ndc         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: openfda: package_ndc         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: openfda: spl_set_id         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: drug_interactions: Prevention or Management: Patients should be monitored closely for more rapid recovery from neuromuscular blockade than expected, and infusion [0m
[31mrate requirements may be higher. EXTENDED PHENYTOIN SODIUM: drug_interactions: Warfarin Increased and decreased PT/INR responses have been reported when phenytoin is co-administered with warfarin [0m
[31mOther Corticosteroids, doxycycline, estrogens, furosemide, oral contraceptives, paroxetine, quinidine, rifampin, sertraline, theophylline, and vitamin D Drugs whose level is decreased by phenytoin [0m
[31mAnticoagulants Apixaban, dabigatran, edoxaban, rivaroxaban Antiepileptic drugs a Carbamazepine, felbamate, lamotrigine, topiramate, oxcarbazepine, lacosamide Antilipidemic agents Atorvastatin, [0m
[31mfluvastatin, simvastatin Antiplatelets Ticagrelor Antiviral agents Efavirenz, lopinavir/ritonavir, indinavir, nelfin EXTENDED PHENYTOIN SODIUM: drug_interactions: avir, ritonavir, saquinavir [0m
[31mFosamprenavir: phenytoin when given with fosamprenavir alone may decrease the concentration of amprenavir, the active metabolite. Phenytoin when given with the combination of fosamprenavir and [0m
[31mritonavir may increase the concentration of amprenavir Calcium channel blockers Nifedipine, nimodipine, nisoldipine, verapamil Other Albendazole [0m[1;31m([0m[31mdecreases active metabolite[0m[1;31m)[0m[31m, chlorpropamide, [0m
[31mclozapine, cyclosporine, digoxin, disopyramide, folic acid, methadone, mexiletine, praziquantel, quetiapine a The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels [0m
[31mis unpredictable [0m[1;31m7[0m[31m. EXTENDED PHENYTOIN SODIUM: drug_interactions: [0m[1;31m3[0m[31m Hyperammonemia with Concomitant Use of Valproate Concomitant administration of phenytoin and valproate has been associated with an [0m
[31mincreased risk of valproate-associated hyperammonemia. Patients treated concomitantly with these two drugs should be monitored for signs and symptoms of hyperammonemia. [0m[1;31m7.4[0m[31m Drug Enteral [0m
[31mFeeding/Nutritional Preparations Interaction Literature reports suggest that patients who have received enteral feeding preparations and/or related nutritional supplements have lower than expected [0m
[31mphenytoin serum levels. It is therefore suggested that phenytoin not be administered concomitantly with an enteral feeding preparation. More frequent serum phenytoin level monitoring may be necessary [0m
[31min these patients. [0m[1;31m7.5[0m[31m Drug/Laboratory Test Interactions Care should be taken when using immunoanalytical methods to measure serum phenytoin concentrations.         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: warnings_and_cautions: Phenytoin induces hepatic metabolizing enzymes. This may enhance the metabolism of vitamin D and decrease vitamin D levels, which may lead to[0m
[31mvitamin D deficiency, hypocalcemia, and hypophosphatemia. Consideration should be given to screening with bone-related laboratory and radiological tests as appropriate and initiating treatment plans [0m
[31maccording to established guidelines. [0m[1;31m5.11[0m[31m Renal or Hepatic Impairment or Hypoalbuminemia Because the fraction of unbound phenytoin is increased in patients with renal or hepatic disease, or in those [0m
[31mwith hypoalbuminemia, the monitoring of phenytoin serum levels should be based on the unbound fraction in those patients. [0m[1;31m5.12[0m[31m Exacerbation of Porphyria In view of isolated reports associating [0m
[31mphenytoin with exacerbation of porphyria, caution should be exercised in using this medication in patients suffering from this disease. [0m[1;31m5[0m[31m. EXTENDED PHENYTOIN SODIUM: warnings_and_cautions: [0m[1;31m13[0m[31m [0m
[31mTeratogenicity and Other Harm to the Newborn Phenytoin may cause fetal harm when administered to a pregnant woman. Prenatal exposure to phenytoin may increase the risks for congenital malformations [0m
[31mand other adverse developmental outcomes [0m[31m. Increased frequencies of major malformations [0m[1;31m([0m[31msuch as orofacial clefts and cardiac defects[0m[1;31m)[0m[31m, and abnormalities characteristic of fetal hydantoin syndrome, [0m
[31mincluding dysmorphic skull and facial features, nail and digit hypoplasia, growth abnormalities [0m[1;31m([0m[31mincluding microcephaly[0m[1;31m)[0m[31m, and cognitive deficits, have been reported among children born to epileptic [0m
[31mwomen who took phenytoin alone or in combination with other antiepileptic drugs during pregnancy. There have been several reported cases of malignancies, including neuroblastoma. EXTENDED PHENYTOIN [0m
[31mSODIUM: warnings_and_cautions: A potentially life-threatening bleeding disorder related to decreased levels of vitamin K-dependent clotting factors may occur in newborns exposed to phenytoin in utero [0m
[31m. This drug-induced condition can be prevented with vitamin K administration to the mother before delivery and to the neonate after birth. [0m[1;31m5.14[0m[31m Hyperglycemia Hyperglycemia, resulting from the drug’s [0m
[31minhibitory effects on insulin release, has been reported. Phenytoin may also raise the serum glucose level in diabetic patients. [0m[1;31m5.15[0m[31m Serum Phenytoin Levels above Therapeutic Range Serum levels of [0m
[31mphenytoin sustained above the therapeutic range may produce confusional states referred to as “delirium,” “psychosis,” or “encephalopathy,” or rarely irreversible cerebellar dysfunction and/or [0m
[31mcerebellar atrophy. Accordingly, at the first sign of acute toxicity, serum levels should be immediately checked. EXTENDED PHENYTOIN SODIUM: warnings_and_cautions: Dose reduction of phenytoin therapy [0m
[31mis indicated if serum levels are excessive; if symptoms persist, termination is recommended.         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m


[31mCONTENT: EXTENDED PHENYTOIN SODIUM: drug_interactions_table: intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, [0m
[31msalicylates, ticlopidine, tolbutamide, trazodone, warfarin<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mcolspan[0m[31m=[0m[31m"2"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Drugs that may decrease phenytoin serum [0m
[31mlevels<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td/><td/><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Antacids <sup>a<[0m[31m/[0m[31msup[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Calcium carbonate, aluminum hydroxide, magnesium hydroxide <content [0m
[31mstyleCode[0m[31m=[0m[31m"italics"[0m[31m>Prevention or Management:<[0m[31m/[0m[31mcontent[0m[31m>Phenytoin and antacids should not be taken at the same time of day <[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Antineop EXTENDED PHENYTOIN SODIUM: [0m
[31mdrug_interactions_table: lastic agents usually in combination<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Bleomycin, carboplatin, cisplatin, doxorubicin, [0m
[31mmethotrexate<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Antiviral agents<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Fosamprenavir, nelfinavir, ritonavir<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Antiepileptic [0m
[31mdrugs<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Carbamazepine, vigabatrin<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Other<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Chronic alcohol abuse, diazepam, diazoxide, folic [0m
[31macid,<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>reserpine, rifampin, St. EXTENDED PHENYTOIN SODIUM: drug_interactions_table: John&#x2019;s wort <sup>b<[0m[31m/[0m[31msup[0m[31m>, sucralfate, theophylline <[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m
[31mcolspan[0m[31m=[0m[31m"2"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Drugs that may either increase or decrease phenytoin serum levels<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td><paragraph>Antiepileptic [0m
[31mdrugs<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td><paragraph>Phenobarbital, valproate sodium <sup>c<[0m[31m/[0m[31msup[0m[31m>, valproic acid <sup>c<[0m[31m/[0m[31msup[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><[0m[31m/[0m[31mtbody[0m[31m><[0m[31m/[0m[31mtable[0m[1;31m>[0m[31m         [0m
[31mSOUR[0m[1;31mCE:E[0m[31mXTENDED PHENYTOIN SODIUM label[0m

[31m        -----[0m
[31m        If NONE of the extracts are relevant, try doing a web search with the[0m
[31m        `relevant_search_extracts` tool/function-call[0m
[31m        [0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m<[0m[1;32mDONE[0m[1;32m>[0m
[32mANSWER: EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, specifically in newborns exposed to phenytoin in utero. A potentially life-threatening bleeding disorder related to decreased [0m
[32mlevels of vitamin K-dependent clotting factors may occur in these newborns. This condition can be prevented with vitamin K administration to the mother before delivery and to the neonate after birth.[0m

[32mSOURCE: EXTENDED PHENYTOIN SODIUM label[0m
[32mEXTRACT_START_END: A potentially life-threatening bleeding disorder related to decreased levels [0m[32m...[0m[32m to the neonate after birth.[0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m FDAHandler [0m [1;34mEntity.USER[0m[1m([0mFDAHandler[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mANSWER: EXTENDED PHENYTOIN SODIUM can increase the risk of [0m
[34mbleeding, specifically in newborns exposed to phenytoin in utero. A potentially life-threatening bleeding disorder related to decreased levels of vitamin K-dependent clotting factors may occur in [0m
[34mthese newborns. This condition can be prevented with vitamin K administration to the mother before delivery and to the neonate after birth.[0m

[34mSOURCE: EXTENDED PHENYTOIN SODIUM label[0m
[34mEXTRACT_START_END: A potentially life-threatening bleeding disorder related to decreased levels [0m[34m...[0m[34m to the neonate after birth.[0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"I asked FDAHandler if EXTENDED PHENYTOIN SODIUM increases or decreases the risk of bleeding."[0m[32m,[0m
[32m      [0m[32m"FDAHandler responded that EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, specifically in newborns exposed to phenytoin in utero. A potentially life-threatening bleeding disorder [0m
[32mrelated to decreased levels of vitamin K-dependent clotting factors may occur in these newborns. This condition can be prevented with vitamin K administration to the mother before delivery and to the [0m
[32mneonate after birth."[0m[32m,[0m
[32m      [0m[32m"The source of this information is the EXTENDED PHENYTOIN SODIUM label."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, particularly in newborns exposed to phenytoin in utero. This increased risk is associated with a potentially [0m
[32mlife-threatening bleeding disorder due to decreased levels of vitamin K-dependent clotting factors. The risk can be mitigated by administering vitamin K to the mother before delivery and to the [0m
[32mneonate after birth."[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m FDAHandler [0m [1;34mEntity.USER[0m[1m([0mFDAHandler[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"I asked FDAHandler if EXTENDED PHENYTOIN SODIUM increases or decreases the risk of bleeding."[0m[34m,[0m
[34m      [0m[34m"FDAHandler responded that EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, specifically in newborns exposed to phenytoin in utero. A potentially life-threatening bleeding disorder [0m
[34mrelated to decreased levels of vitamin K-dependent clotting factors may occur in these newborns. This condition can be prevented with vitamin K administration to the mother before delivery and to the [0m
[34mneonate after birth."[0m[34m,[0m
[34m      [0m[34m"The source of this information is the EXTENDED PHENYTOIN SODIUM label."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, particularly in newborns exposed to phenytoin in utero. This increased risk is associated with a potentially [0m
[34mlife-threatening bleeding disorder due to decreased levels of vitamin K-dependent clotting factors. The risk can be mitigated by administering vitamin K to the mother before delivery and to the [0m
[34mneonate after birth."[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does EXTENDED PHENYTOIN SODIUM increase or decrease the risk of bleeding?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. I asked FDAHandler if EXTENDED PHENYTOIN SODIUM increases or decreases the risk of bleeding.[0m
[1;31m2[0m[31m. FDAHandler responded that EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, specifically in newborns exposed to phenytoin in utero. A potentially life-threatening bleeding disorder [0m
[31mrelated to decreased levels of vitamin K-dependent clotting factors may occur in these newborns. This condition can be prevented with vitamin K administration to the mother before delivery and to the [0m
[31mneonate after birth.[0m
[1;31m3[0m[31m. The source of this information is the EXTENDED PHENYTOIN SODIUM label.[0m
[31m        -----[0m
[31m        Final answer: EXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, particularly in newborns exposed to phenytoin in utero. This increased risk is associated with a potentially [0m
[31mlife-threatening bleeding disorder due to decreased levels of vitamin K-dependent clotting factors. The risk can be mitigated by administering vitamin K to the mother before delivery and to the [0m
[31mneonate after birth.[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m""[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>     AGENT[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m""[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31mYour reasoning is valid, no feedback was provided.[0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.USER [0m
 [1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0morchestrator-bleeding-EXTENDED PHENYTOIN SODIUM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m<[0m[1;32mDONE[0m[1;32m>[0m

[32mEXTENDED PHENYTOIN SODIUM can increase the risk of bleeding, particularly in newborns exposed to phenytoin in utero. This increased risk is associated with a potentially life-threatening bleeding [0m
[32mdisorder due to decreased levels of vitamin K-dependent clotting factors. The risk can be mitigated by administering vitamin K to the mother before delivery and to the neonate after birth. This [0m
[32minformation is sourced from the EXTENDED PHENYTOIN SODIUM label.[0m
